Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthopediatrics (KIDS) Gains from Investment Securities (2020 - 2025)

Historic Gains from Investment Securities for Orthopediatrics (KIDS) over the last 6 years, with Q3 2025 value amounting to $1.5 million.

  • Orthopediatrics' Gains from Investment Securities changed N/A to $1.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.5 million, marking a year-over-year increase of 17591666.67%. This contributed to the annual value of $9.0 million for FY2024, which is 40057.05% up from last year.
  • Latest data reveals that Orthopediatrics reported Gains from Investment Securities of $1.5 million as of Q3 2025.
  • In the past 5 years, Orthopediatrics' Gains from Investment Securities registered a high of $5.7 million during Q4 2024, and its lowest value of -$23.0 million during Q3 2022.
  • Moreover, its 5-year median value for Gains from Investment Securities was -$6000.0 (2023), whereas its average is -$1.2 million.
  • In the last 5 years, Orthopediatrics' Gains from Investment Securities crashed by 150909.09% in 2022 and then surged by 9571666.67% in 2024.
  • Orthopediatrics' Gains from Investment Securities (Quarter) stood at -$5.5 million in 2021, then soared by 91.29% to -$480000.0 in 2022, then skyrocketed by 98.75% to -$6000.0 in 2023, then surged by 95716.67% to $5.7 million in 2024, then plummeted by 73.84% to $1.5 million in 2025.
  • Its Gains from Investment Securities was $1.5 million in Q3 2025, compared to $1.6 million in Q2 2025 and $1.7 million in Q1 2025.